Aberdeen Asset Management plc Given Outperform Rating at RBC Capital (ADN)
Aberdeen Asset Management plc (LON:ADN)‘s stock had its “outperform” rating restated by equities research analysts at RBC Capital in a research note issued to investors on Thursday, Analyst Ratings.Net reports. They currently have a GBX 480 ($7.76) target price on the stock. RBC Capital’s target price indicates a potential upside of 6.57% from the stock’s previous close.
Shares of Aberdeen Asset Management plc (LON:ADN) traded up 5.83% on Thursday, hitting GBX 450.40. 9,162,471 shares of the company’s stock traded hands. Aberdeen Asset Management plc has a 52 week low of GBX 317.80 and a 52 week high of GBX 492.20. The stock has a 50-day moving average of GBX 381.1 and a 200-day moving average of GBX 405.2. The company’s market cap is £5.121 billion.
ADN has been the subject of a number of other recent research reports. Analysts at Shore Capital Stockbrokers reiterated a “buy” rating on shares of Aberdeen Asset Management plc in a research note to investors on Thursday. Separately, analysts at UBS AG reiterated a “neutral” rating on shares of Aberdeen Asset Management plc in a research note to investors on Wednesday. They now have a GBX 404 ($6.53) price target on the stock. Finally, analysts at BNP Paribas reiterated an “outperform” rating on shares of Aberdeen Asset Management plc in a research note to investors on Monday. They now have a GBX 525 ($8.49) price target on the stock. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of GBX 470.16 ($7.60).
Aberdeen Asset Management PLC is an international asset management company investing across the four main asset classes of equity, fixed income, property and alternative investment strategies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.